Health care stocks advanced Wednesday afternoon, with the NYSE Health Care Index rising 1% and the Health Care Select Sector SPDR Fund (XLV) up 0.7%.
The iShares Biotechnology ETF (IBB) added 0.8%.
In corporate news, Novo Nordisk's (NVO) Q1 results topped Wall Street's projections, while the Danish drugmaker tempered its 2025 sales outlook as competition from compounded obesity and diabetes drugs in the US impacted the early part of the year. Novo shares rose 1.2%.
Teva Pharmaceutical Industries (TEVA) surged nearly 9% after it posted higher Q1 non-GAAP earnings and net revenue.
Immunocore (IMCR) shares jumped 8%. The company reported Q1 net income Wednesday of $0.10 per diluted share, swinging from a loss of $0.49 a year earlier. Analysts polled by FactSet expected a loss of $0.38.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。